Ethmozine: Electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias

This publication has 16 references indexed in Scilit:

• Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: Results of a prospective, controlled trial
  The American Journal of Cardiology, 1984
• Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.
  Circulation, 1984
• Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safety
  American Heart Journal, 1983
• Fast and slow idioventricular rhythms in the canine heart: A study of their mechanism using antiarrhythmic drugs and electrophysiologic testing
  The American Journal of Cardiology, 1982
• Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.
  Circulation, 1980
• Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and tolerance
  American Heart Journal, 1979
• Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
  Circulation, 1978
• New antiarrhythmic agents: Amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil
  The American Journal of Cardiology, 1978
• Effects of the phenothiazine analog, EN-313, on ventricular arrhythmias in the dog
  European Journal of Pharmacology, 1977
• Significance of the Sinus-Node Recovery Time
  Circulation, 1972